Clinical trial Recruiting at 1 site Observational Ages 50 to 70

Epicardial Fat Thickness and Heart Risk in Adults Aged 50-70

Official title: Epicardial Fat Tissue Assessed by Echocardiography in Russian and Asian Populations: Association With Chronic Non-Communicable Diseases and Risk Factors

Run by National Medical Research Center for Therapy and Preventive Medicine · NCT07604610 · Data updated 2026-11-12

This study will see if the thickness of epicardial fat helps predict heart and metabolic risks in adults aged 50-70 from several countries.

More Non Communicable Chronic Diseases trials

Quick facts

Study typeObservational
Ages50 Years to 70 Years
SexAll
Enrollment500 (estimated)
SponsorNational Medical Research Center for Therapy and Preventive Medicine
Government
Locations1 site (Moscow)
StatusRecruiting
StartedMay 4, 2026
Main results expectedMarch 2027
Study endsMarch 2028
Registry record updatedMay 22, 2026
Trial IDNCT07604610 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50-70 undergoing transthoracic echocardiography who can consent and have suitable image quality.

Probably not a fit

Patients with unsuitable echocardiographic images or those outside the age range may not derive direct benefit from EFT measurements in this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort will measure epicardial fat tissue (EFT) thickness using transthoracic echocardiography and relate it to clinical, laboratory, and anamnestic data. It will examine how EFT correlates with cardiac structure and function, and with other risk factors associated with metabolic and cardiovascular disease. The study will identify EFT thresholds linked to myocardial remodeling and will follow participants by phone to track outcomes and the prognostic value of EFT thickness for a composite endpoint. Data will come from patients undergoing echocardiography in Russia and Central Asia, with a focus on aging populations at risk for non-communicable diseases.

Why it matters

Potential benefit: If EFT thickness proves a strong prognostic marker, clinicians could better stratify cardiovascular risk and tailor preventive strategies.

How similar studies have gone: Previous research has linked EFT with cardiovascular and metabolic risk, but this specific multinational cohort focuses on threshold values and prognosis, representing a relatively novel approach in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 50-70 years undergoing transthoracic echocardiography in inpatient or outpatient settings;
* Ability and willingness to provide informed consent.

Exclusion Criteria:

* Refusal to sign informed consent;
* Inability to perform transthoracic echocardiography or poor image quality;
* Severe psychiatric disorders.

Where it's running

  • National Medical Research Center for Therapy and Preventive Medicine
    Moscow, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.